TVGN (Tevogen Bio Holdings) Ending Cash Position : $1.28 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Ending Cash Position?

Tevogen Bio Holdings's Ending Cash Position for the quarter that ended in Dec. 2024 was $1.28 Mil.

Tevogen Bio Holdings's quarterly Ending Cash Position increased from Jun. 2024 ($1.14 Mil) to Sep. 2024 ($2.33 Mil) but then declined from Sep. 2024 ($2.33 Mil) to Dec. 2024 ($1.28 Mil).

Tevogen Bio Holdings's annual Ending Cash Position increased from Dec. 2022 ($0.13 Mil) to Dec. 2023 ($1.05 Mil) and increased from Dec. 2023 ($1.05 Mil) to Dec. 2024 ($1.28 Mil).

Tevogen Bio Holdings Ending Cash Position Historical Data

The historical data trend for Tevogen Bio Holdings's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Ending Cash Position Chart

Tevogen Bio Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

7.12

0.13

1.05

1.28

Tevogen Bio Holdings Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial					1.05	1.32	1.14	2.33	1.28

Tevogen Bio Holdings Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Tevogen Bio Holdings's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.053	+	0.23
	=	1.28

Tevogen Bio Holdings's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.331	+	-1.048
	=	1.28

Tevogen Bio Holdings Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Tevogen Bio Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (NAS:TVGN) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

G28:Germany

Address

15 Independence Boulevard, Warren, NJ, USA, 07059

Website

https://www.tevogen.com

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.